Scientists found a natural defense against protein buildup, opening a new path to preventive treatments.

The Claude maker's 5% share pledge, worth $48bn, is a bid to win over regulators and investors before its stock market listing.

The bank is moving off its balance sheet to back robot factories, hypersonic missiles, and supply chains, signaling a new era of bank-backed military innovation.

The AI giant's philanthropic fund is real, but its value is a bet on the sector's staying power.

New research links a modest daily walk to less tau buildup and nearly half the cognitive and functional decline, even for those with early signs.

The consulting giant's strategic review of its Greater China unit could set a benchmark for every multinational weighing its China exposure.

The Atlassian cofounder is rolling out a protocol that makes AI agents visible, governed team members, and keeps accountability with the human user.

Tech leaders want the shares given directly to Americans, not parked in a foundation.

The AI company is locking a slice of its value to social causes before a potential November IPO, with roughly 20% of shares now pledged to the public good.

A Savannah officer's shared credential let an ICE agent run hundreds of plate searches on Hispanic drivers, exposing a surveillance backdoor.

The YouTube-native studio is expanding beyond platform revenue with a four-acre LA campus and partnerships with Disney and Fox. Here's what it means for media executives.

The chip giant's deal with Apollo, BlackRock, and KKR signals that capital markets, not engineering, now decide who builds AI.